Cenovus Energy Shares Climb After Quarterly Results, Drop in Debt
By Robb M. Stewart
Cenovus Energy's shares jumped Thursday after the Canadian energy company logged a stronger-than-expected result for the final quarter of 2023 and made progress toward its debt target.
In morning trading, the shares were 5.6% higher at C$23.21 in Toronto, narrowing their decline over the last 12 months to 11%. On the New York Stock Exchange, Cenovus was up 6.4% at $17.29, and is now down 11% from a year ago.
The oil and natural-gas company reported net earnings of 743 million Canadian dollars ($548.6 million), or C$0.39 a share, down from C$784 million, or C$0.39, a year earlier as it was squeezed by lower commodity prices and refinery crack spreads, as well as the cost of processing crude bought in earlier periods at higher prices.
Adjusted fund flows per share fell to C$1.09 for the quarter from C$1.81, but topped the consensus expectation of analysts of C$1.01, a beat Jefferies analyst Lloyd Byrne said was tied to beats by Cenovus' conventional and offshore operations.
Revenue for the quarter fell 6.6% to C$13.1 billion from C$14.1 billion last year, with lower revenue in both its upstream and downstream divisions.
Production for the period averaged 808,600 barrels of oil equivalent a day, up from 797,000 the year before and ahead of the 805,300 expected by analysts. Downstream throughput fell 13% to 579,100 barrels a day on average.
Cenovus reduced net debt by C$916 million in the quarter, taking it to C$5.1 billion, and it said it continues to make progress toward its net debt target of C$4 billion.
"Debt remains low on both an absolute and relative basis, and we question why Cenovus does not move to increase shareholder returns sooner," Jefferies' Byrne said.
Write to Robb M. Stewart at robb.stewart@wsj.com
(END) Dow Jones Newswires
February 15, 2024 11:29 ET (16:29 GMT)
Copyright (c) 2024 Dow Jones & Company, Inc.-
What History Tells Us About the Fed’s Next Move
-
What’s Happening In the Markets This Week
-
Alphabet’s New Dividend: What Investors Need to Know
-
Going Into Earnings, Is Palantir Stock a Buy, a Sell, or Fairly Valued?
-
Going Into Earnings, Is Eli Lilly Stock a Buy, a Sell, or Fairly Valued?
-
What’s the Difference Between the CPI and PCE Indexes?
-
5 Stocks to Buy That We Still Like After They’ve Run Up
-
Markets Brief: Stocks Are Starting to Look Cheap Again
-
AbbVie Earnings: Next-Generation Immunology Drugs Help Offset Humira Biosimilar Pressure
-
Exxon Earnings: Ignore Earnings Shortfall as Long-Term Growth and Improvement on Track
-
American Airlines Earnings: We See Costs Overshadowing Market Share This Year
-
Snap Earnings: Advertising Growth and Snapchat+ Drive Monetization
-
STMicro Earnings: We Still See an Attractive Margin of Safety Despite a Poor First-Half Forecast
-
Alphabet Shares Surge on Strong Earnings, Dividend Surprise
-
Microsoft Earnings: Firm Beats Forecasts on Strong AI and Cloud Demand
-
PG&E Earnings: Near-Term Regulatory Certainty Supports Industry-Leading Earnings Growth